🔬 Analysis Details
Can CSF p-tau217 normalization serve as a reliable surrogate endpoint for determining donanemab cessation thresholds?
completed
neurodegeneration
🧪 7 hypotheses
📓 0 notebooks
$0.00
Can CSF p-tau217 normalization serve as a reliable surrogate endpoint for determining donanemab cessation thresholds?